FLIR Cancelling Contract With X.Labs / Feevr

By John Honovich, Published May 20, 2020, 07:39am EDT

While X.Labs announced the signing of a new agreement with FLIR on May 12, 2020, FLIR said, in response, on May 18, 2020, that they had cancelled a previous contract and are in the process of cancelling a second contract.

IPVM Image

Fever Detection Controversy

The use of fever, or in the case of X.Labs, "feevr" detectors are growing along with increasing controversy. For example, the Washington Post declared last week "Thermal scanners are the latest technology being deployed to detect the coronavirus. But they don’t really work."

X.Labs ********* ******

****** ****, *.**** "*****" product *** ****** ********* for *** ********* ** a "***** ********* ******" with ******* ******** (±*.*°*) which ** ******* **** Dahua, ****, *********, ***. at * ******** ** those ********* ******, ** they ********* ** *****"***** ** ***********" ********.

Accuracy ********

**** ** **** ***** is **** *.**** **** they *** ***** ***** *** *** ********** ******* *** ~$***,*** ****, *** ************** ***** *********** / 'feevr' ******** ******* *** accuracy ** ********* ** just ~±*°*.

X.Labs ************

** *** **, ****,*.**** *********"*** ******* ** * product ****** ********* **** FLIR ********** *******"*** *** ************ ******** no ***** *** **** from ****.

*.**** ***, ** ********, recently**** * ******* ***********:

*** **** *** **** FLIR ****** * *** agreement **** *** ******* in ***** *** **** is ***** ** **** effect. **** **** ** attached ** ** ******* to *** ******

*******, ***** *** ** copy *** ******* ********* any **** ********* ** the ****** / *********.

*** *** *** ** SDS, *****'* ******* ***********, who ** **** ***.**** ***** ******, ******************:

IPVM Image

FLIR **** **********

*******, ****, ** *** 18, ****, ********* ** IPVM's ******* ** *.**** announcement ***** **** ******.**** ******** ** ****** Relations *** *************:

** *** *** ******** contract **** ***** ********/***** that ** ********* *** I *** ******* ** are ** *** ******* of ********** * ****** contract **** **** ***.

*.**** *** *** ******* to ****'* ******* *** comment ** ****'* ********.

Other ******* ********* **** *** *** *** '*****' ********* *******

********, *** *** ***** company,*****, **** *** **** publicly ********* '*****' ********* using * **** *** Pro ******** ******* ***** marketing ************ * ********** *************** **** **** *** endorse ** ******* ***** app:

IPVM Image

FLIR *** *** *** ******** *** ***** *********

**** *** **** ********** from *** ***** ** the *********** ******** **** FLIR *** *** ******* are *** ******** *** 'fever' ********* ***** ** FLIR's *** ****-******** ******** specifications.

***** *** ****** ** certainly ******* *** ********* to ****** *** **** the ****** ** ***********, as *** ********** **** so ***** ****** **** week, *** ******* ** whether ***** ******* "***'* really ****."

Comments (22)

Undisclosed Integrator #1

05/20/20 12:21pm

Agree
Disagree
Informative
Unhelpful
Funny: 20

Undisclosed Manufacturer #2

05/20/20 05:39pm

IPVM Image

Agree
Disagree
Informative
Unhelpful
Funny

Undisclosed Manufacturer #3

05/20/20 09:47pm

******** ***** ******** ***'* really **** ******, *** we're *** ******* ****. Fever *********, **** **** masks, ****** ****** ******** is *** **** ** a ***** ******** ***** and **'* **** *********. We *** **** ** be **** ******* **** usual ******* **** ********* enemy **** ** *****-**, and *** ** ***** solutions ***** **** ********* awareness ********** ** *** arguable *************.

Agree: 2
Disagree: 3
Informative
Unhelpful: 1
Funny: 1

Undisclosed Manufacturer #2

In reply to Undisclosed Manufacturer #3 | 05/20/20 10:25pm

*** *** **** ******* guidance ** *** ******** risk ** ******* ******* to ***.

*** *********** ******* | CDC

* ** *** ** favor ** **** **** gestures **** ******* **** have * ******** ****** on **********/*********.

Agree: 3
Disagree
Informative
Unhelpful
Funny

John Honovich

IPVM | In reply to Undisclosed Manufacturer #3 | 05/20/20 10:29pm

*** ** ***** ********* raise **** ********* ********* regardless ** *** ******** effectiveness.

*** ******* ********:

*. ** *** ****** a ******** ****** ****** to ** **** ******** in ***** *****, ** poses * ****, *.*., if ****** ******* **** fevers *** ***** ** get ******, **** *** be **** ****** ** maintain ****** ********, **** hands, ***.

*. ** ****** ****** to ****** ******** **** are ** ********* ** possible, *.*., ** * 'fever ******' ******** **% of ****** *** ******* captures **** **% ** should *** ** ********** those *********** *** ****** the ***** ** ***** ones **** ******* **** vs *****.

Agree: 5
Disagree
Informative
Unhelpful
Funny

Ben Clay

In reply to John Honovich | 05/21/20 09:37am

*’* *** **** ** makes ***** **** **** 100% ******** ***** **** up ** **% ** COVID ******** *** ************. Would *** ****** **’* of ********* ** ** Intrusion ****** **** * 20% ********* ****?

********** * ***** **** the **** ***** ********* solutions *** ****** ** do **** ****** **** good ** ****** * false ***** ** ******** as *** **** ***** point. **** **** *** for *** ******** ******.

Agree: 10
Disagree
Informative
Unhelpful
Funny

Undisclosed Manufacturer #3

In reply to Ben Clay | 05/22/20 10:41pm

*** * **** ** 80% ************? *** **** today **’* **% ************, up **** **% ** April.

**** **’* ********* **** is ** ******* *** is ********* ** ********* demographics. ** *** *** detection ** **** ****** might ****** ** ***** than **** *******.

**’* ********* ** *** agree ** **** ****, it’s ** *** ***** of **** ********** ********** of **** **** ** thermal *********.

Agree
Disagree
Informative
Unhelpful
Funny

Ben Clay

In reply to Undisclosed Manufacturer #3 | 05/23/20 05:03am

** *** ******** *** that ****** **% **** Asymptomatic ** **** ********. Presumably ***** **** **** be ******** **** *** pre-symptomatic. * ***’* ***** you **** **** *** to ** ******** ****** of **** % ***** present ******* * *****, but *** ***** ** it ** *********** (*** I ******* * ********). So *** ****** ** that ************* *** (***-)*** to ******* **** **** can ***** **** **** a *** *******.

Agree
Disagree
Informative
Unhelpful
Funny

Undisclosed Manufacturer #3

In reply to Ben Clay | 05/23/20 05:46am

**** ** *** *** info ******?

Agree
Disagree
Informative
Unhelpful
Funny

Ben Clay

In reply to Undisclosed Manufacturer #3 | 05/23/20 07:05am

*** ********, **** *:*&*: ********* *** *****-** - ************ *** ***********

Agree
Disagree
Informative
Unhelpful
Funny

Undisclosed Manufacturer #3

In reply to Ben Clay | 05/23/20 12:58pm

****** ***.

** ** ************* **** info **** **** ******* in ****.

“*** *****-**, **** ** date ******* **** **% of ********** *** **** or ************, **% *** severe *********, ********* ****** and *% *** ******** infections”

**% ** ******** **** didn’t ******* ******* *************** and ******. **** ** not ** *** **** were *** ************, ** absolutely **** ****’* *** the ****. **** ** get **** **** ******, stay **** *** ******* (considered **** *****). **** guidelines *** *** **** we **** ** ** on *** ** ******* for *** ****** ** 65% ***********.

Agree
Disagree
Informative
Unhelpful
Funny

Ben Clay

In reply to Undisclosed Manufacturer #3 | 05/23/20 01:50pm

* ***** ** *** agree ** ** **** enough ** ******* ****** every ****** ** ***** a **** $** *********** and ****** **** ** stay ** **** ** they **** * ***** or ***** ******** ;-)

Agree
Disagree
Informative
Unhelpful
Funny

Undisclosed Manufacturer #3

In reply to Ben Clay | 05/23/20 02:01pm

** ***, ****** :)

Agree
Disagree
Informative
Unhelpful
Funny
Avatar

Blaine D'Amico

In reply to Undisclosed Manufacturer #3 | 05/23/20 03:41pm

*** ********** ********* *** all **** *** ***. This ******* ******** ******** different ********** ******** ***************-**: **** ********** *** asymptomatic? - ******** *% ** ** the **% ****** **** WHO. ***** ** ** that ****** ****** ***** at **** ***** ***** may **** ** **** never **** *** ****.

Agree
Disagree
Informative
Unhelpful
Funny

Undisclosed Integrator #5

In reply to John Honovich | 05/21/20 10:13pm

** *** ****** ******* 75% *** *** ***** only **%. ** ****** combine **** ** **** into * ****** ******* that ******* ***%***** *** marketing *****.

Agree
Disagree
Informative
Unhelpful
Funny: 2

Undisclosed Manufacturer #3

05/21/20 12:05am

******, ****** ****** *** excellence.

Agree: 1
Disagree
Informative
Unhelpful
Funny

Undisclosed #4

05/21/20 03:10am

**** ** ******* ** do ******* **** ** comes ** ********** *** spread ** *****-**?

**** ** ************* ******** * *************'* ***********

Agree
Disagree
Informative
Unhelpful
Funny

Andrew Somerville

In reply to Undisclosed #4 | 05/21/20 08:38am

*** **** ** ******* these ******? ** ******* the ****** ** ********** measures ** **** * significant ******. ****** - the ****** ***** *** no ******** - *** had ** ******* ** new ***** ******* *** 30 *** *** ** and *** ***** *** now ******* ** *** the ***** ** ***** Korea, * *** ****** country.

IPVM Image

Agree: 2
Disagree
Informative: 3
Unhelpful
Funny

Terrence Harless

In reply to Andrew Somerville | 05/21/20 01:18pm

* ******* ****** ** relying ** **** ********... So *** **** ******** should **, **** ** the ********** ** ****** of *** ********. ******'* plan ** ** ********** the '**********' ***** *** 'non-vulnerable' ****** ***** **** on ****** ***** *****.

Agree
Disagree
Informative
Unhelpful
Funny

Undisclosed #4

In reply to Andrew Somerville | 05/23/20 12:30am

* ** *** ****** his ******** ** *******....

* ** ****** ****** that ** ******** *** positions ** *** *** best ************* ** *** to ****** **** ******.

*** ***, * **** math ** ****** **** anything **** **** ** comes ** ********** ******** - ** **** ** it ** ********* ****** and *********.

Agree
Disagree
Informative
Unhelpful
Funny

Undisclosed Integrator #6

05/25/20 04:34am

***** ***** **** ** a ******** ****** *** get ** *** *******.

******* ****** ***** ***** & ***** ******** ** CBS****************.

Agree
Disagree
Informative
Unhelpful
Funny

Ben Clay

In reply to Undisclosed Integrator #6 | 05/25/20 05:56am

** **** *** ***. He ***** ** **** this ********** ** ******* that *** **** ** looking ** *** ************ like *****. *** *** TSA ****** ***** ** use * ****** **** the *** *** ******* stated ** *** ********...***** on ******* ***.

Agree: 1
Disagree
Informative: 1
Unhelpful
Funny
Read this IPVM report for free.

This article is part of IPVM's 6,888 reports, 921 tests and is only available to members. To get a one-time preview of our work, enter your work email to access the full article.

Already a member? Login here | Join now
Loading Related Reports